OTCMKTS:BIEI

Premier Biomedical (BIEI) Stock Price, News & Analysis

$0.0012
0.00 (0.00%)
(As of 04/22/2024 ET)
Today's Range
$0.0012
$0.0013
50-Day Range
N/A
52-Week Range
$0.0005
$0.0017
Volume
806,228 shs
Average Volume
1.78 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BIEI stock logo

About Premier Biomedical Stock (OTCMKTS:BIEI)

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.

BIEI Stock Price History

BIEI Stock News Headlines

Incredible Opportunity to Retire FAST!
A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.
Southwest Premier Card Review 2024
BIEI Premier Biomedical, Inc.
Incredible Opportunity to Retire FAST!
A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.
Premier Biomedical, Inc. (BIEI)
Premier Biomedical Inc (BIEI)
See More Headlines
Receive BIEI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Premier Biomedical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:BIEI
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. David Caplan
    President, Chairman of the Board of Directors, Secretary & Treasurer
  • Mr. Gustavo Carreño
    Chief Technology Officer
  • Mr. Carl Eller
    Marketing & Planning Vice-President

BIEI Stock Analysis - Frequently Asked Questions

How have BIEI shares performed in 2024?

Premier Biomedical's stock was trading at $0.0009 at the start of the year. Since then, BIEI shares have increased by 33.3% and is now trading at $0.0012.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Premier Biomedical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Premier Biomedical investors own include Co-Diagnostics (CODX), Allena Pharmaceuticals (ALNA), CytoDyn (CYDY), Inovio Pharmaceuticals (INO), Sierra Oncology (SRRA), Vaxart (VXRT), MEI Pharma (MEIP), Novavax (NVAX), Rigel Pharmaceuticals (RIGL) and Selecta Biosciences (SELB).

How do I buy shares of Premier Biomedical?

Shares of BIEI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BIEI) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners